NMDP, Minneapolis, MN 55401, USA.
CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN 55401, USA.
Cells. 2024 May 29;13(11):933. doi: 10.3390/cells13110933.
NMDP recognizes that despite advances in hematopoietic stem cell transplantation (HSCT) and other cell therapies, not all patients have equitable access to treatment, and disparities in outcomes remain. This paper explores the recent work of NMDP to accelerate progress and expand access to more patients through transformative clinical research, particularly in the use of mismatched unrelated donors for HSCT.
NMDP 认识到，尽管造血干细胞移植（HSCT）和其他细胞疗法取得了进展，但并非所有患者都能平等获得治疗，治疗结果仍存在差异。本文探讨了 NMDP 最近的工作，通过变革性临床研究加速进展并扩大更多患者的治疗机会，特别是在 HSCT 中使用不匹配的无关供体方面。
Zotero 插件